Baltimore County Public Schools Superintendent Myriam Rogers presented a $2.98 billion total operating budget to the school ...

Piers Morgan's show devolved into chaos Thursday after he cut the mic on a guest who bizarrely called him "sweetheart" and ...

Arabian Business unveils its 2025 list of 100 Most Inspiring Women, showcasing the female leaders transforming the Middle ...

Researchers have discovered a biological mechanism that makes plant roots more welcoming to beneficial soil microbes.

Merus is a buy with Bizengri approval for NRG1+ cancers, Petosemtamab's potential, and partnership with BHVN for oncology ...

A review of a conservative approach to investing, focusing on capital preservation, income generation, and goal setting.

Bezuclastinib's upcoming data in July 2025 could be a game-changer for COGT, offering a lucrative investment opportunity. See ...

Read here for more on the potential of RCUS's combination therapies for various cancers, with promising Phase 3 trials and ...

Option Care gets 75% of its revenues from chronic therapies and 25% from acute treatments, but its growth now looks ...

Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...

Xenon has promising Phase 2 data for MDD treatment, robust financials, and a potential in niche markets, despite premium ...

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes ...